Key insights
- Lam Research (LRCX) reported strong Q2 earnings and revenue, beating analyst estimates. While Q3 EPS guidance was mixed, the revenue outlook was largely in line with expectations. The company's stock has shown significant gains over the past year. Positive EPS revisions in the last 90 days and a "great performance" financial health score suggest continued strength in the semiconductor equipment sector, potentially providing a positive signal for related technology stocks.
Investing.com - Lam Research (NASDAQ: LRCX) reported second quarter EPS of $7.52, $0.45 better than the analyst estimate of $7.07. Revenue for the quarter came in at $3.76B versus the consensus estimate of $3.7B.
Lam Research sees Q3 2024 EPS of $6.15-$7.65 versus the analyst consensus of $6.64.
Lam Research sees Q3 2024 revenue of $3.40B-$4.00B versus the analyst consensus of $3.68B.
Lam Research's stock price closed at $848.16. It is up 45.23% in the last 3 months and up 73.66% in the last 12 months.
Lam Research saw 15 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Lam Research's stock price’s past reactions to earnings here.
According to InvestingPro, Lam Research's Financial Health score is "great performance".
Check out Lam Research's recent earnings performance, and Lam Research's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Most traders can read a chart. The hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. That's the conviction gap — and our chart analysis closes it. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. Know exactly what to do next, every time.